Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
69.83
+0.03 (0.04%)
At close: Nov 4, 2025, 4:00 PM EST
69.85
+0.02 (0.03%)
After-hours: Nov 4, 2025, 6:27 PM EST
Avidity Biosciences Market Cap
Avidity Biosciences has a market cap or net worth of $10.03 billion as of November 4, 2025. Its market cap has increased by 76.52% in one year.
Market Cap
10.03B
Enterprise Value
8.85B
1-Year Change
76.52%
Ranking
Category
Stock Price
$69.83
Market Cap Chart
Since June 12, 2020, Avidity Biosciences's market cap has increased from $1.01B to $10.03B, an increase of 895.67%. That is a compound annual growth rate of 53.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 10.03B | 189.00% |
| Dec 31, 2024 | 3.47B | 417.36% |
| Dec 29, 2023 | 670.62M | -54.52% |
| Dec 30, 2022 | 1.47B | 32.27% |
| Dec 31, 2021 | 1.11B | 16.40% |
| Dec 31, 2020 | 957.68M | -4.94% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 796.00B |
| Johnson & Johnson | 448.42B |
| AbbVie | 376.49B |
| UnitedHealth Group | 304.77B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Abbott Laboratories | 216.37B |
| Novo Nordisk | 216.34B |